Skip to main content

Table 1 The characteristics of included patients

From: The deep vein thrombosis of lower limb after total hip arthroplasty: what should we care

Variables DVT group(n = 36) Non-DVT group(n = 146) χ2/t P
Male/female 20/16 92/54 1.046 0.102
Age(y) 72.14 ± 8.02 68.11 ± 9.35 4.328 0.025
BMI(kg/m2) 28.26 ± 4.55 26.02 ± 3.29 3.144 0.032
Diabetes 19(52.78 %) 25(17.12 %) 1.118 0.009
Hypertension 21(58.33 %) 77(52.71 %) 1.207 0.068
Hyperlipidemia 10(27.78 %) 42(28.77 %) 1.084 0.106
Preoperative D-dimer (mg/L) 0.69 ± 0.11 0.66 ± 0.12 1.230 0.074
Number of replacement joints     
Unilateral 11(30.56 %) 38(26.03 %) 1.140 0.031
Bilateral 25(69.44 %) 108(73.97 %)
Duration of surgery(min) 133.62 ± 30.18 102 ± 27.42 9.124 0.015
Type of Anesthesia     
General anesthesia 16(44.44 %) 68(46.57 %) 1.122 0.078
Epidural anesthesia 20(55.56 %) 78(53.42 %)
Type of prosthesis     
Biological prosthesis 6(16.67 %) 72(49.32 %) 1.205 0.036
Cemented prosthesis 30(83.33 %) 74(50.68 %)
Duration of days in bed 4.24 ± 1.22 2.79 ± 1.02 1.177 0.042
Anticoagulant drugs     
Rivaroxaban 22(61.11 %) 85(58.22 %) 1.145 0.103
Low-molecular weight heparin calcium 14(38.89 %) 61(41.78 %)